FilingSEC EDGAR10-Q
Scribe Therapeutics Raises $140.7 Million Net Proceeds via IPO and Private Placement
· SEC accepted
StageFinancing Completed
Filing content
Scribe Therapeutics secured approximately $140.7 million in net proceeds through its IPO and concurrent private placement, alleviating going concern doubts.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…